Nicotinic Agonists Market

Nicotinic receptor agonists bind to the same receptor site as acetylcholine and favor the conformational changes of the protein towards the open state. These agonists are, for example, suberyldicholine, carbachol and PTMA (phenyl trimethyl ammonium).

Nicotinic Agonists Market contains market size and forecasts of Nicotinic Agonists in global, including the following market information:

• Global Nicotinic Agonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Nicotinic Agonists Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Nicotinic Agonists companies in 2021 (%)

The global Nicotinic Agonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nicotine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nicotinic Agonists include FORUM Pharmaceuticals, Karuna Pharmaceuticals, Sumitomo Dainippon Pharma Co, BMS, Oyster Point Pharma, Jiangsu Hansoh Pharmaceutical and Dalian Meilun Biotech Co, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

surveyed the Nicotinic Agonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nicotinic Agonists Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nicotinic Agonists Market Segment Percentages, by Type, 2021 (%)

• Nicotine
• Acetylcholine
• Carbachol
• Epibatidine
• Others

Global Nicotinic Agonists Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nicotinic Agonists Market Segment Percentages, by Application, 2021 (%)

• Alzheimer's Disease (AD)
• Schizophrenia
• Others

Global Nicotinic Agonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nicotinic Agonists Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Nicotinic Agonists revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Nicotinic Agonists revenues share in global market, 2021 (%)
• Key companies Nicotinic Agonists sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Nicotinic Agonists sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• FORUM Pharmaceuticals
• Karuna Pharmaceuticals
• Sumitomo Dainippon Pharma Co
• BMS
• Oyster Point Pharma
• Jiangsu Hansoh Pharmaceutical
• Dalian Meilun Biotech Co